title: Development of transient phage resistance in Campylobacter coli against the group II phage CP84.
abstract: Recently, there is a growing interest in the use of bacteriophages for pre- and post-harvest applications to reduce foodborne pathogens (including Campylobacter) along the food chain. Quantitative Campylobacter reductions of up to three log10 units have been achieved by phage application. However, possible phage resistance might limit this approach. In Campylobacter (C.) jejuni, phage resistance mechanisms have been described in detail but data on these mechanisms in C. coli are still missing. To study phage resistance in C. coli, strain NCTC 12668 was infected with the lytic phage CP84, belonging to group II of Campylobacter phages. Resistant and sensitive clones were analysed using phenotypic and genotypic assays. C. coli clones acquired only transient resistance against CP84. The resistance led to cross-protection to one out of five other group II phages tested. Phage resistance was apparently neither caused by large genomic rearrangements nor by a CRISPR system. Binding assays demonstrated that CP84 could not adsorb to resistant C. coli clones suggesting a bacterial phage receptor to be involved in resistance. However, phage resistant C. coli clones did not reveal an altered motility or modified flaA sequence. Considering the loss of binding capacity and the reversion to a phage sensitive phenotype we hypothesize that acquired resistance depends on temporal phase variable switch-off modifications of the phage receptor genes, even though the resistance mechanism could not be elucidated in detail. We further speculate that even closely related phages of the same group use different bacterial receptors for binding on C. coli.
authors: Stefanie
authors: S
authors: Orquera
authors: Stefan
authors: S
authors: Hertwig
authors: Thomas
authors: T
authors: Alter
authors: Jens A
authors: JA
authors: Hammerl
authors: Alice
authors: A
authors: Jirova
authors: Greta
authors: G
authors: Gölz
mesh_terms: D001435:Bacteriophages / Q000502:physiology*; D002169:Campylobacter Infections / Q000517:prevention & control*; D017000:Campylobacter coli / Q000502:physiology* / Q000821:virology*; D003140:Communicable Disease Control / Q000379:methods*; D054884:Host-Pathogen Interactions; D010641:Phenotype